{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:03:47Z","timestamp":1789362227762,"version":"build-2803163510"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001455","name":"American Foundation for Suicide Prevention","doi-asserted-by":"publisher","award":["ECR-0-137-23"],"award-info":[{"award-number":["ECR-0-137-23"]}],"id":[{"id":"10.13039\/100001455","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.euroneuro.2026.112888","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:10:46Z","timestamp":1784326246000},"page":"112888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Emerging pharmacological and neuromodulation interventions for suicidal ideation and behaviour"],"prefix":"10.1016","volume":"112","author":[{"given":"Mauro","family":"Scala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Magrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0359-4471","authenticated-orcid":false,"given":"Ivana","family":"Leccisotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4363-3759","authenticated-orcid":false,"given":"Alessandro","family":"Serretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9015-4203","authenticated-orcid":false,"given":"Xenia","family":"Gonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Sankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8130-437X","authenticated-orcid":false,"given":"Raffaella","family":"Calati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8278-191X","authenticated-orcid":false,"given":"Siegfried","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Altamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6139-1920","authenticated-orcid":false,"given":"Marco","family":"Colizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7930-563X","authenticated-orcid":false,"given":"Giuseppe","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.euroneuro.2026.112888_bib0001","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1176\/appi.ajp.2017.16010034","article-title":"A 5-year observational study of patients with treatment-resistant depression treated with vagus nerve stimulation or treatment as usual: comparison of response, remission, and suicidality","volume":"174","author":"Aaronson","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112888_bib0002","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3389\/fpsyt.2019.00929","article-title":"Anti-suicidal efficacy of repetitive transcranial magnetic stimulation in depressive patients: a retrospective analysis of a large sample","volume":"10","author":"Abdelnaim","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0003","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s13063-018-2843-9","article-title":"The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial","volume":"19","author":"Ahmadi","year":"2018","journal-title":"Trials"},{"issue":"7","key":"10.1016\/j.euroneuro.2026.112888_bib0004","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","year":"2023","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41398-019-0377-x","article-title":"Placebo aiTBS attenuates suicidal ideation and frontopolar cortical perfusion in major depression","volume":"9","author":"Baeken","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112888_bib0006","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jad.2018.05.065","article-title":"Medical and non-medical marijuana use in depression: longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization","volume":"241","author":"Bahorik","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2026.112888_bib0007","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpsychires.2015.06.003","article-title":"Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant","volume":"68","author":"Ballard","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2026.112888_bib0008","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.psychres.2017.07.065","article-title":"Active suicidal ideation during clinical antidepressant trials","volume":"257","author":"Ballard","year":"2017","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0009","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/sltb.12663","article-title":"Clinical trials for rapid changes in suicidal ideation: lessons from ketamine","volume":"51","author":"Ballard","year":"2021","journal-title":"Suicide Life-Threat. Behav."},{"issue":"11","key":"10.1016\/j.euroneuro.2026.112888_bib0010","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.biopsych.2021.01.013","article-title":"Translating interventional neuroscience to suicide: it's about time","volume":"89","author":"Barredo","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2026.112888_bib0011","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/da.22863","article-title":"Consistency of trajectories of suicidal ideation and depression symptoms: evidence from a randomized controlled trial","volume":"36","author":"Batterham","year":"2019","journal-title":"Depress. Anxiety"},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0012","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/cns.13971","article-title":"Therapeutic potential of brain stimulation techniques in the treatment of mental, psychiatric, and cognitive disorders","volume":"29","author":"Camacho-Conde","year":"2023","journal-title":"CNS Neurosci. Ther"},{"key":"10.1016\/j.euroneuro.2026.112888_bib0013","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1196\/annals.1440.010","article-title":"The adolescent brain","volume":"1124","author":"Casey","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2026.112888_bib0014","article-title":"Efficacy and tolerability of repetitive transcranial magnetic stimulation on suicidal ideation: a systemic review and meta-analysis","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"12","key":"10.1016\/j.euroneuro.2026.112888_bib0015","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/s41386-019-0480-y","article-title":"Maintenance of antidepressant and antisuicidal effects by d-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo\u2013control study","volume":"44","author":"Chen","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"15","key":"10.1016\/j.euroneuro.2026.112888_bib0016","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1017\/S0033291720001221","article-title":"Effect of the NMDA receptor partial agonist, d-cycloserine, on emotional processing and autobiographical memory","volume":"51","author":"Chen","year":"2021","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0017","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1038\/s41598-020-61694-9","article-title":"Temporal association between zolpidem medication and the risk of suicide: a 12-year population-based, retrospective cohort study","volume":"10","author":"Cho","year":"2020","journal-title":"Sci. Rep."},{"issue":"jun27 4","key":"10.1016\/j.euroneuro.2026.112888_bib0018","doi-asserted-by":"crossref","first-page":"f3646","DOI":"10.1136\/bmj.f3646","article-title":"Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis","volume":"346","author":"Cipriani","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2026.112888_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.109851","article-title":"Incidence of suicide and self-harm among people with opioid use disorder and the impact of opioid agonist treatment: a retrospective data linkage study","volume":"246","author":"Colledge-Frisby","year":"2023","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"10.1016\/j.euroneuro.2026.112888_bib0020","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","article-title":"Anticholinergic drug exposure and the risk of dementia: a nested case-control study","volume":"179","author":"Coupland","year":"2019","journal-title":"JAMA Intern. Med"},{"key":"10.1016\/j.euroneuro.2026.112888_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.764183","article-title":"Efficacy of transcranial magnetic stimulation for reducing suicidal ideation in depression: a meta-analysis","volume":"12","author":"Cui","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112888_bib0022","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1590\/1516-4446-2019-0690","article-title":"Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a \u201creal-world\u201d chart review study","volume":"42","author":"De Berardis","year":"2020","journal-title":"Braz. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2026.112888_bib0023","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/17434440.2021.1909470","article-title":"The future of neuromodulation: smart neuromodulation","volume":"18","author":"De Ridder","year":"2021","journal-title":"Expert Rev. Med. Devices"},{"key":"10.1016\/j.euroneuro.2026.112888_bib0024","article-title":"Accelerated intermittent theta burst stimulation for suicide risk in therapy-resistant depressed patients: a randomized, sham-controlled trial","volume":"10","author":"Desmyter","year":"2016","journal-title":"Fronti. Hum. Neurosci."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40360-020-0391-x","article-title":"Antiviral treatment perspective against Borna disease virus 1 infection in major depression: a double-blind placebo-controlled randomized clinical trial","volume":"21","author":"Dietrich","year":"2020","journal-title":"BMC Pharmacol. Toxicol"},{"issue":"8","key":"10.1016\/j.euroneuro.2026.112888_bib0026","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41562-023-01605-w","article-title":"A systematic review of psychosocial functioning changes after gender-affirming hormone therapy among transgender people","volume":"7","author":"Doyle","year":"2023","journal-title":"Nat. Hum. Behav."},{"issue":"9","key":"10.1016\/j.euroneuro.2026.112888_bib0027","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1177\/02698811251338214","article-title":"Set and setting of psychedelics for therapeutic use in psychiatry: a systematic review","volume":"39","author":"Estric","year":"2025","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2026.112888_bib0028","unstructured":"FDA, 2012. Guidance for industry suicidal ideation and behavior: prospective assessment of occurrence in clinical trials."},{"issue":"Supplement_4","key":"10.1016\/j.euroneuro.2026.112888_bib0029","doi-asserted-by":"crossref","DOI":"10.1093\/eurpub\/ckaf161.1888","article-title":"Economic burden of suicide in Sweden in 2022","volume":"35","author":"Feldman","year":"2025","journal-title":"Eur. J. Public Health"},{"issue":"2","key":"10.1016\/j.euroneuro.2026.112888_bib0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/medicina60020283","article-title":"Brexpiprazole attenuates aggression, suicidality and substance use in Borderline Personality Disorder: a case series","volume":"60","author":"Francis","year":"2024","journal-title":"Medicina (B Aires)"},{"issue":"2","key":"10.1016\/j.euroneuro.2026.112888_bib0031","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1037\/bul0000084","article-title":"Risk factors for suicidal thoughts and behaviors: a meta-analysis of 50 years of research","volume":"143","author":"Franklin","year":"2017","journal-title":"Psychol. Bull."},{"issue":"11","key":"10.1016\/j.euroneuro.2026.112888_bib0032","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/jamapsychiatry.2022.2990","article-title":"Association between folic acid prescription fills and suicide attempts and intentional self-harm among privately insured US adults","volume":"79","author":"Gibbons","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112888_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115054","article-title":"Benztropine and suicide attempts and intentional self-harm","volume":"320","author":"Gibbons","year":"2023","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112888_bib0034","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.psychres.2014.12.004","article-title":"Treatment-related improvement in neuropsychological functioning in suicidal depressed patients: paroxetine vs. bupropion","volume":"225","author":"Gorlyn","year":"2015","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112888_bib0035","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/npp.2011.247","article-title":"Pilot randomized clinical trial of an SSRI vs bupropion: effects on suicidal behavior, ideation, and mood in major depression","volume":"37","author":"Grunebaum","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.euroneuro.2026.112888_bib0036","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1176\/appi.ajp.2017.17060647","article-title":"Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial","volume":"175","author":"Grunebaum","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0037","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41386-023-01614-3","article-title":"Therapeutic potential of N-methyl-d-aspartate receptor modulators in psychiatry","volume":"49","author":"Hanson","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"09","key":"10.1016\/j.euroneuro.2026.112888_bib0038","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/a-2453-0910","article-title":"Psychedelika in der psychiatrie: eine offene debatte","volume":"93","author":"Herwig","year":"2025","journal-title":"Fortschr. Neurol. Psychiatr."},{"issue":"11","key":"10.1016\/j.euroneuro.2026.112888_bib0039","article-title":"Newer generation antidepressants for depressive disorders in children and adolescents","volume":"2021","author":"Hetrick","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.euroneuro.2026.112888_bib0040","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/aje\/kwad237","article-title":"Prediction of suicide attempts among persons with depression: a population-based case cohort study","volume":"193","author":"Jiang","year":"2024","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0041","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/02698811211058923","article-title":"MDMA\/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults","volume":"36","author":"Jones","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2026.112888_bib0042","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jad.2017.09.018","article-title":"Suicidal ideation declines with improvement in the subjective symptoms of major depression","volume":"227","author":"Keilp","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2026.112888_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2021.660926","article-title":"A systematic review of neuromodulation treatment effects on suicidality","volume":"15","author":"Kucuker","year":"2021","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.euroneuro.2026.112888_bib0044","doi-asserted-by":"crossref","first-page":"k3532","DOI":"10.1136\/bmj.k3532","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)","author":"Langan","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/13811118.2024.2322128","article-title":"Clinical trials studying suicide risk reduction: who is excluded from participation","volume":"29","author":"Lawrence","year":"2025","journal-title":"Arch. Suicide Res."},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112888_bib0046","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22m14587","article-title":"The protective effect of clozapine on suicide: a population mortality study of statewide autopsy records in Maryland","volume":"84","author":"Lee","year":"2023","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0047","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/s12916-024-03645-z","article-title":"Risk of suicide in patients with atrial fibrillation receiving different oral anticoagulants: a nationwide analysis using target trial emulation framework","volume":"22","author":"Li","year":"2024","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0048","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41398-023-02707-9","article-title":"Targeting suicidal ideation in major depressive disorder with MRI-navigated Stanford accelerated intelligent neuromodulation therapy","volume":"14","author":"Li","year":"2024","journal-title":"Transl. Psychiatry"},{"issue":"17","key":"10.1016\/j.euroneuro.2026.112888_bib0049","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.3390\/nu15173859","article-title":"Folate and its significance in depressive disorders and suicidality: a comprehensive narrative review","volume":"15","author":"Liwinski","year":"2023","journal-title":"Nutrients."},{"issue":"2","key":"10.1016\/j.euroneuro.2026.112888_bib0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/brainsci15020161","article-title":"Emerging medications for treatment-resistant depression: a review with perspective on mechanisms and challenges","volume":"15","author":"Lucido","year":"2025","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0051","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1186\/s12889-021-11010-5","article-title":"Production losses attributable to suicide deaths in European Union","volume":"21","author":"\u0141yszczarz","year":"2021","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112888_bib0052","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1017\/S109285291900097X","article-title":"Suicidal ideation and behavior in adults with major depressive disorder treated with vortioxetine: post hoc pooled analyses of randomized, placebo-controlled, short-term and open-label, long-term extension trials","volume":"25","author":"Mahableshwarkar","year":"2020","journal-title":"CNS. Spectr."},{"key":"10.1016\/j.euroneuro.2026.112888_bib0053","doi-asserted-by":"crossref","unstructured":"Martone, A., Folego-Temoteo, I., Fries, G.R., Docherty, A.R., Ashley-Koch, A.E., European College of Neuropsychopharmacology Network on Suicide Research and Prevention, Bandeira, C.E., Grevet, E.H., Bau, C.H.D., Bralten, J., Fabbri, C., Serretti, A., Rovaris, D.L., Fanelli, G., 2025. Dissecting the pleiotropic genetic architecture of suicide attempt, suicidal ideation, and thirteen correlated traits. https:\/\/doi.org\/10.64898\/2025.12.07.25341749.","DOI":"10.64898\/2025.12.07.25341749"},{"key":"10.1016\/j.euroneuro.2026.112888_bib0054","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.euroneuro.2022.12.011","article-title":"Prevention of suicide by clozapine in mental disorders: systematic review","volume":"69","author":"Masdrakis","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.euroneuro.2026.112888_bib0055","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1176\/appi.ajp.2019.19030267","article-title":"Reducing suicidal ideation through insomnia treatment (REST-IT): a randomized clinical trial","volume":"176","author":"McCall","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.euroneuro.2026.112888_bib0056","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.14650","article-title":"Developing an ethics and policy framework for psychedelic clinical care: a consensus statement","volume":"7","author":"McGuire","year":"2024","journal-title":"JAMA Netw. Open."},{"issue":"5","key":"10.1016\/j.euroneuro.2026.112888_bib0057","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/jcm14051416","article-title":"Psychedelics and suicide-related outcomes: a systematic review","volume":"14","author":"Meshkat","year":"2025","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.euroneuro.2026.112888_bib0058","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141606","article-title":"Single-item measurement of suicidal behaviors: validity and consequences of misclassification","volume":"10","author":"Millner","year":"2015","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0059","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40345-023-00308-5","article-title":"NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial","volume":"11","author":"Nierenberg","year":"2023","journal-title":"Int. J. Bipolar. Disord."},{"issue":"9","key":"10.1016\/j.euroneuro.2026.112888_bib0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.31919","article-title":"Early access to testosterone therapy in transgender and gender-diverse adults seeking masculinization: a randomized clinical trial","volume":"6","author":"Nolan","year":"2023","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.euroneuro.2026.112888_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.nsa.2025.105520","article-title":"Electroconvulsive therapy reduces suicidality and all-cause mortality in refractory depression: a systematic review and meta-analysis of neurostimulation studies","volume":"4","author":"Odermatt","year":"2025","journal-title":"Neurosci. Appl."},{"issue":"14","key":"10.1016\/j.euroneuro.2026.112888_bib0062","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3390\/healthcare12141435","article-title":"Effects of digital psychotherapy on suicide: a systematic review and meta-analysis","volume":"12","author":"Oh","year":"2024","journal-title":"Healthcare"},{"issue":"2","key":"10.1016\/j.euroneuro.2026.112888_bib0063","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S2215-0366(21)00392-8","article-title":"Self-harm and suicide during and after opioid agonist treatment among primary care patients in England: a cohort study","volume":"9","author":"Padmanathan","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2026.112888_bib0064","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/cpt.1858","article-title":"Neuronavigation-guided rTMS for the treatment of depressive patients with suicidal ideation: a double-blind, randomized, sham-controlled trial","volume":"108","author":"Pan","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.euroneuro.2026.112888_bib0065","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/YIC.0000000000000225","article-title":"Effects of anxiety on suicidal ideation: exploratory analysis of a paroxetine versus bupropion randomized trial","volume":"33","author":"Parris","year":"2018","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.euroneuro.2026.112888_bib0066","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/ageing\/afaa090","article-title":"Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis","volume":"49","author":"Pieper","year":"2020","journal-title":"Age Ageing"},{"issue":"12","key":"10.1016\/j.euroneuro.2026.112888_bib0067","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia\u2013Suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112888_bib0068","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/psych4030038","article-title":"Pharmacological strategies for suicide prevention based on the social pain model: a scoping review","volume":"4","author":"Rajkumar","year":"2022","journal-title":"Psych."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0069","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.clinph.2020.10.003","article-title":"Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: expert Guidelines","volume":"132","author":"Rossi","year":"2021","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.euroneuro.2026.112888_bib0070","first-page":"1","article-title":"Magnetoencephalographic signatures of facial emotion processing in schizophrenia and major depressive disorder: a systematic review","author":"Scala","year":"2026","journal-title":"Neuropsychobiol"},{"issue":"6","key":"10.1016\/j.euroneuro.2026.112888_bib0071","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1017\/S1092852924002268","article-title":"The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges","volume":"29","author":"Scala","year":"2024","journal-title":"CNS Spectr."},{"issue":"5","key":"10.1016\/j.euroneuro.2026.112888_bib0072","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/YIC.0000000000000488","article-title":"Clinical specificity profile for novel rapid acting antidepressant drugs","volume":"38","author":"Scala","year":"2023","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2026.112888_bib0073","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/13651501.2025.2560357","article-title":"Asenapine for aggressive behaviours in psychiatric disorders: a systematic review of efficacy and real-world effectiveness","volume":"29","author":"Scala","year":"2025","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"1\u20132","key":"10.1016\/j.euroneuro.2026.112888_bib0074","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jad.2011.03.050","article-title":"The gender paradox in suicidal behavior and its impact on the suicidal process","volume":"138","author":"Schrijvers","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112888_bib0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/pds.5407","article-title":"Core concepts in pharmacoepidemiology: confounding by indication and the role of active comparators","volume":"31","author":"Sendor","year":"2022","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"9","key":"10.1016\/j.euroneuro.2026.112888_bib0076","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1111\/bcp.15360","article-title":"Ketamine for suicidality: an umbrella review","volume":"88","author":"Shamabadi","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0077","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/19585969.2023.2231466","article-title":"Suicidality risk after using cannabis and cannabinoids: an umbrella review","volume":"25","author":"Shamabadi","year":"2023","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2026.112888_bib0078","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jad.2020.08.051","article-title":"Effect of adjunctive pimavanserin on suicidal ideation in patients with major depression: analysis of the CLARITY study","volume":"277","author":"Shelton","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0079","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41398-024-02973-1","article-title":"A meta-analysis of the effects of ketamine on suicidal ideation in depression patients","volume":"14","author":"Shen","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112888_bib0080","doi-asserted-by":"crossref","DOI":"10.1017\/S0033291724003313","article-title":"Intermittent theta-burst stimulation with adjunctive d-cycloserine rapidly resolves suicidal ideation and decreases implicit association with death\/suicide","volume":"55","author":"Sohn","year":"2025","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.euroneuro.2026.112888_bib0081","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jamapsychiatry.2015.3097","article-title":"Indicators for remission of suicidal ideation following magnetic seizure therapy in patients with treatment-resistant depression","volume":"73","author":"Sun","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0082","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41398-018-0302-8","article-title":"Magnetic seizure therapy reduces suicidal ideation and produces neuroplasticity in treatment-resistant depression","volume":"8","author":"Sun","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112888_bib0083","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jpsychires.2024.05.043","article-title":"Is serum homocysteine level a biomarker of suicide attempts: a preliminary study","volume":"175","author":"Susam","year":"2024","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112888_bib0084","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.amepre.2021.02.026","article-title":"Association between buprenorphine for opioid use disorder and mortality risk","volume":"61","author":"Vakkalanka","year":"2021","journal-title":"Am. J. Prev. Med."},{"issue":"8","key":"10.1016\/j.euroneuro.2026.112888_bib0085","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4088\/JCP.08m04943","article-title":"Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study","volume":"70","author":"Valuck","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0086","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jamapsychiatry.2024.2854","article-title":"Suicidal ideation and suicide attempts after direct or indirect psychotherapy: a systematic review and meta-analysis","volume":"82","author":"Van Ballegooijen","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2026.112888_bib0087","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40263-024-01078-z","article-title":"An evidence-based update on anticholinergic use for drug-induced movement disorders","volume":"38","author":"Vanegas-Arroyave","year":"2024","journal-title":"CNS Drugs"},{"issue":"10","key":"10.1016\/j.euroneuro.2026.112888_bib0088","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70077","article-title":"Efficacy and safety of transcranial direct current stimulation as an add-on trial treatment for acute bipolar depression patients with suicidal ideation","volume":"30","author":"Wang","year":"2024","journal-title":"CNS. Neurosci. Ther."},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112888_bib0089","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11692","article-title":"Bilateral repetitive transcranial magnetic stimulation decreases suicidal ideation in depression","volume":"79","author":"Weissman","year":"2018","journal-title":"J. Clin. Psychiatry"},{"issue":"8","key":"10.1016\/j.euroneuro.2026.112888_bib0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7434","article-title":"Magnetic seizure therapy for suicidality in treatment-resistant depression","volume":"3","author":"Weissman","year":"2020","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.euroneuro.2026.112888_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2022.107343","article-title":"Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults","volume":"132","author":"Yang","year":"2022","journal-title":"Addict. Behav."},{"issue":"3","key":"10.1016\/j.euroneuro.2026.112888_bib0093","first-page":"221","article-title":"Designing clinical trials to assess the impact of pharmacological treatment for suicidal ideation\/behavior: issues and potential solutions","volume":"37","author":"Yao","year":"2023","journal-title":"Pharmaceut. Med."},{"issue":"5","key":"10.1016\/j.euroneuro.2026.112888_bib0094","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1176\/appi.ajp.2015.15040535","article-title":"Ultra-low-dose buprenorphine as a time-limited treatment for severe suicidal ideation: a randomized controlled trial","volume":"173","author":"Yovell","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2026.112888_bib0095","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3389\/fphar.2019.01325","article-title":"The impact of Ayahuasca on suicidality: results from a randomized controlled trial","volume":"10","author":"Zeifman","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.euroneuro.2026.112888_bib0096","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00213-020-05692-9","article-title":"Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial","volume":"238","author":"Zeifman","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.euroneuro.2026.112888_bib0097","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.biopsych.2023.12.013","article-title":"Comparisons of accelerated continuous and intermittent theta burst stimulation for treatment-resistant depression and suicidal ideation","volume":"96","author":"Zhao","year":"2024","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2026.112888_bib0098","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/appi.focus.20220076","article-title":"Pharmacologic approaches to suicide prevention","volume":"21","author":"Zisook","year":"2023","journal-title":"Focus (Madison)"},{"issue":"6","key":"10.1016\/j.euroneuro.2026.112888_bib0099","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3390\/ijerph22060890","article-title":"Suicide-related mortality trends in Europe, 2012\u20132021","volume":"22","author":"Zuin","year":"2025","journal-title":"Int. J. Environ. Res. Public Health"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X2600129X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X2600129X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T04:26:26Z","timestamp":1789359986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X2600129X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":98,"alternative-id":["S0924977X2600129X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2026.112888","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging pharmacological and neuromodulation interventions for suicidal ideation and behaviour","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2026.112888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112888"}}